中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/6358
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1994695      Online Users : 459
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/6358


    Title: Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy
    Authors: 李瑤玲(Lee YL);施純明(Chuen-Ming Shih);邱慧玲(Chiou HL);蕭明裕(Shiau MY);張基晟(Chang GC);張懿欣(Chang YH*)*
    Contributors: 健康照護學院二年制呼吸治療學系學士班在職專班;中國附醫內科部胸腔科
    Keywords: Anti-p53 autoantibodies;Lung cancer;Chemotherapy
    Date: 2004-11
    Issue Date: 2009-08-25 15:49:02 (UTC+8)
    Abstract: "BACKGROUND: Correlation between p53 autoantibodies (p53 Abs) titers and the efficacy of Taiwanese lung cancer patients undergoing chemotherapy has never been investigated. Our present study aimed at evaluating putative possibility of using p53 Abs levels as a model system to monitor effect of chemotherapy and prognosis prediction of lung cancer.

    METHODS: The prevalence of p53 Abs in lung cancer patients and temporal alteration of p53 Abs titers in lung cancer patients carrying p53 Abs were investigated by using ELISA and Western blot analysis.

    RESULTS: p53 Abs was detected in 17 of 277 (6.14%) lung cancer patients, the positivity of p53 Abs in patients with small cell lung carcinoma and non-small cell lung carcinoma was 4.88% and 6.36%, respectively. No significant association between p53 Abs and patients' clinical manifestations was found. Titer of p53 Abs was decreased in 6 of 17 p53 Abs-carrying patients after chemotherapy. However, the decreasing p53 Abs titers were not correlated with patients' survival or chemotherapeutic efficacy.

    CONCLUSIONS: The prevalence of p53 Abs in Taiwanese lung cancer is much lower than that in Caucasians. It is unlikely that p53 Abs titer could be a monitoring indicator for the chemotherapeutic efficacy or a prognosis indicator of lung cancer."
    Relation: CLINICA CHIMICA ACTA 349(349)87~96
    Appears in Collections:[Department of Respiratory Therapy] Journal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback